Data / Drug companies / Perrigo Direct, Inc
Perrigo Direct, Inc: 120 products in the FDA NDC directory, labeler code 50804
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Perrigo Direct, Inc (labeler code 50804) lists 120 products in the FDA National Drug Code Directory, covering 74 finished drugs by generic name. By type: 120 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 9, 2026.
The request: Watch Perrigo Direct, Inc (FDA labeler code 50804): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50804
- Products in commercial distribution
- 120
- Packages
- 133
- Finished drugs by generic name
- 74
- Prescription products
- 0
- Over the counter products
- 120
- Flagged as original packager
- 117 of 117 products that carry the flag
- Started marketing in the last 12 months
- 2
- Products with a marketing end date set
- 4
- Earliest marketing start
- September 15, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 118 | 98.3% |
| Generic drugs (ANDA) | 1 | 0.8% |
| New drug applications (NDA) | 1 | 0.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 120 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 18 | 15% |
| Tablet, chewable | 12 | 10% |
| Tablet, coated | 9 | 7.5% |
| Tablet | 9 | 7.5% |
| Solution | 7 | 5.8% |
| Suspension | 6 | 5% |
| Lozenge | 5 | 4.2% |
| Tablet, film coated | 5 | 4.2% |
| Capsule, liquid filled | 4 | 3.3% |
| Shampoo | 4 | 3.3% |
| Lotion | 3 | 2.5% |
| Tablet, effervescent | 3 | 2.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ibuprofen | 50804-185 | Capsule, liquid filled | Generic drugs (ANDA) | September 9, 2026 |
| Gentle Laxative | 50804-329 | Tablet, delayed release | Over the counter monograph drugs | July 17, 2026 |
| GoodSense Medicated Chest Rub | 50804-205 | Ointment | Over the counter monograph drugs | September 1, 2025 |
| GoodSense Petroleum Jelly | 50804-050 | Jelly | Over the counter monograph drugs | September 1, 2025 |
| GoodSense Hemorrhoidal Pain Relief | 50804-317 | Cream | Over the counter monograph drugs | May 1, 2025 |
| GoodSense Ear Wax Removal Kit | 50804-117 | Liquid | Over the counter monograph drugs | May 1, 2025 |
| GoodSense Anti-Itch | 50804-064 | Spray | Over the counter monograph drugs | May 1, 2025 |
| Extra Strength Smooth Antacid Assorted Fruits | 50804-179 | Tablet, chewable | Over the counter monograph drugs | February 28, 2025 |
| Extra Strength Gas Relief Cherry | 50804-134 | Tablet, chewable | Over the counter monograph drugs | February 28, 2025 |
| GoodSense Cooling Pain Relief | 50804-297 | Gel | Over the counter monograph drugs | February 17, 2025 |
| Goodsense Fiber laxative 147 | 50804-147 | Tablet | Over the counter monograph drugs | January 9, 2025 |
| GoodSense Tussin CF Multi-Symptom Cold, Raspberry | 50804-256 | Liquid | Over the counter monograph drugs | November 5, 2024 |
| Goodsense maximum strength Stomach Relief 528 | 50804-154 | Liquid | Over the counter monograph drugs | September 13, 2024 |
| Goodsense Extra Strength Antacid | 50804-151 | Tablet, chewable | Over the counter monograph drugs | September 13, 2024 |
| Cough and Cold HBP | 50804-689 | Tablet, film coated | Over the counter monograph drugs | September 10, 2024 |
| Goodsense Regular strength Stomach Relief 122 | 50804-152 | Tablet, chewable | Over the counter monograph drugs | September 9, 2024 |
| Stool Softener | 50804-424 | Capsule, liquid filled | Over the counter monograph drugs | June 18, 2024 |
| Sleep Aid | 50804-410 | Capsule, liquid filled | Over the counter monograph drugs | June 18, 2024 |
| Senna Laxative | 50804-372 | Tablet | Over the counter monograph drugs | June 18, 2024 |
| Stimulant Laxative Plus Stool Softener | 50804-304 | Tablet, film coated | Over the counter monograph drugs | June 1, 2024 |
| Eye Itch Relief | 50804-601 | Solution/ drops | New drug applications (NDA) | April 1, 2024 |
| Good Sense Effervescent Pain Relief | 50804-422 | Tablet, effervescent | Over the counter monograph drugs | March 25, 2024 |
| Allergy Relief | 50804-048 | Tablet | Over the counter monograph drugs | January 26, 2024 |
| Therapeutic tar anti-dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis | 50804-887 | Shampoo | Over the counter monograph drugs | January 18, 2024 |
| GoodSense Regular Strength Antacid | 50804-112 | Tablet, chewable | Over the counter monograph drugs | December 7, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.